News Daily News Low Bleeding Risk With Abelacimab in AF Patients Undergoing Invasive Procedures Todd Neale June 10, 2025
News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI Todd Neale August 31, 2024
News Conference News EACTS 2023 Combined Surgical and Catheter Ablation Best for Persistent AF Michael O'Riordan October 12, 2023
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Conference News HRS 2021 STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation Todd Neale July 29, 2021
News Daily News ‘Nontrivial’ Amount of LA Thrombus Found Before AF Procedures Todd Neale June 08, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Conference News ESC 2019 LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17 Todd Neale September 10, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News EHRA 2019 Edoxaban Joins Other NOACs as Option During Catheter Ablation for A-fib Todd Neale March 21, 2019
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Conference News AHA 2017 ‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry Todd Neale November 22, 2017
News Daily News Dabigatran Reversal Agent Yields No Surprises in Final RE-VERSE AD Study Results Todd Neale July 14, 2017
News Conference News ACC 2017 RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest Yael L. Maxwell March 20, 2017
News Daily News AHA Wades Into Conversation Over Periprocedural Use of Non-Vitamin K Antagonist Oral Anticoagulants Yael L. Maxwell February 13, 2017